Stock Ratios
Making an investment decision in the stock market involves a certain amount of risk, so it's important to thoroughly review a company's stock before making any decisions. Stock float, number of short positions and outstanding shares are among the many factors an investor should take into account.
profit margin TTM
-4613.11%
operating margin TTM
-4824.94%
revenue TTM
N/A
revenue per share TTM
0.0$
valuation ratios | |
|---|---|
| pe ratio | -3.35 |
| peg ratio | -0.08 |
| price to book ratio | 16.42 |
| price to sales ratio | 163.58 |
| enterprise value multiple | -3.33 |
| price fair value | 16.42 |
profitability ratios | |
|---|---|
| gross profit margin | -1025.61% |
| operating profit margin | -4824.94% |
| pretax profit margin | -4613.11% |
| net profit margin | -4613.11% |
| return on assets | -75.45% |
| return on equity | -188.27% |
| return on capital employed | -90.42% |
liquidity ratios | |
|---|---|
| current ratio | 3.05 |
| quick ratio | 3.05 |
| cash ratio | 1.50 |
efficiency ratios | |
|---|---|
| days of inventory outstanding | 0.00 |
| operating cycle | 0.00 |
| days of payables outstanding | 46.24 |
| cash conversion cycle | -46.24 |
| receivables turnover | 0.00 |
| payables turnover | 7.89 |
| inventory turnover | 0.00 |
debt and solvency ratios | |
|---|---|
| debt ratio | 0.45 |
| debt equity ratio | 2.83 |
| long term debt to capitalization | 0.00 |
| total debt to capitalization | 0.74 |
| interest coverage | 0.00 |
| cash flow to debt ratio | -1.39 |
cash flow ratios | |
|---|---|
| free cash flow per share | -0.89 |
| cash per share | 0.54 |
| operating cash flow per share | -0.88 |
| free cash flow operating cash flow ratio | 1.01 |
| cash flow coverage ratios | -1.39 |
| short term coverage ratios | 0.00 |
| capital expenditure coverage ratio | -195.80 |
Frequently Asked Questions
When was the last time Prime Medicine, Inc. (NASDAQ:PRME) reported earnings?
Prime Medicine, Inc. (PRME) published its most recent earnings results on 06-08-2026.
What is Prime Medicine, Inc.'s current ROE?
An investor's main concern is the profitability ratios of a company so that they are able to understand how it performs financially. Investors are interested in finding out how effectively a business is using their cash to produce earnings, which is why return on equity (ROE) ratio is important. Prime Medicine, Inc. (NASDAQ:PRME)'s trailing twelve months ROE is -188.27%.
What are ROA telling us?
The Return on Assets (ROA) ratio measures how profitable a company is relative to its total assets. Prime Medicine, Inc. (PRME) currently has a ROA of -75.45%. Companies that manage their assets effectively will have greater returns, while those that do so poorly would suffer lower returns.
Where did PRME's net profit margin stand at?
PRME reported a profit margin of -4613.11% in the last quarter. A company's profit margin, also known as its revenue ratio or gross profit ratio, reflects the amount of revenue that an organization earns compared to its net income. In general, a higher ratio implies greater profit, and vice versa.
What is PRME's short-term liquidity position?
Apple's current ratio, which measures its ability to pay short-term obligations, was 3.05 in the most recent quarter. The quick ratio stood at 3.05, with a Debt/Eq ratio of 2.83.